These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10096381)

  • 1. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
    Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
    Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
    Silberman MA; Partin AW; Veltri RW; Epstein JI
    Cancer; 1997 Feb; 79(4):772-9. PubMed ID: 9024715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
    Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
    de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
    Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
    Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
    Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
    Revelos K; Petraki C; Scorilas A; Stefanakis S; Malovrouvas D; Alevizopoulos N; Kanellis G; Halapas A; Koutsilieris M
    Anticancer Res; 2007; 27(5B):3651-60. PubMed ID: 17972531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvessel density in prostate carcinoma.
    Bono AV; Celato N; Cova V; Salvadore M; Chinetti S; Novario R
    Prostate Cancer Prostatic Dis; 2002; 5(2):123-7. PubMed ID: 12497001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Connelly RR; Moul JW
    J Urol; 1998 Aug; 160(2):459-65. PubMed ID: 9679898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
    Grossfeld GD; Carroll PR; Lindeman N; Meng M; Groshen S; Feng AC; Hawes D; Cote RJ
    Urology; 2002 Jan; 59(1):97-102. PubMed ID: 11796289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.
    Strohmeyer D; Rössing C; Strauss F; Bauerfeind A; Kaufmann O; Loening S
    Prostate; 2000 Jan; 42(1):26-33. PubMed ID: 10579796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease.
    Di Lorenzo G; De Placido S; Autorino R; De Laurentiis M; Mignogna C; D'Armiento M; Tortora G; De Rosa G; D'Armiento M; De Sio M; Bianco AR; D'Armiento FP
    Prostate Cancer Prostatic Dis; 2005; 8(1):54-9. PubMed ID: 15655565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.
    Offersen BV; Borre M; Overgaard J
    APMIS; 1998 Apr; 106(4):463-9. PubMed ID: 9637268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
    Krupski T; Petroni GR; Frierson HF; Theodorescu JU
    Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
    Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
    Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of microvessel density in prostate cancer core biopsy.
    Dugonjić AS; Usaj SK; Eri Z; Latinović LT
    Vojnosanit Pregl; 2015 Apr; 72(4):317-27. PubMed ID: 26040177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.